Press Releases

April 25, 2017

Josef Penninger receives CEE Innovation Award

Vienna, April 25th 2017 For his extraordinary scientific achievements and his international pioneering role in genetics and cancer research Josef Penninger, Scientific Director of IMBA (Austrian Institute of Molecular Biotechnology of the Austrian Academy of Sciences) was awarded the second CEE Innovation Award.

April 11, 2017

Tuberculosis: Researchers Uncover how Bacteria Burst our Cells

Scientists based in Vienna unveil the complex molecular structure that causes lethal infections by Mycobacterium tuberculosis (Mtb). Their findings might have implications for potential therapies against antibiotic-resistant tuberculosis.

April 06, 2017

Researchers initiate cross-disciplinary bioethics symposium at IMBA

Inquisitiveness, academic freedom, and a pioneer spirit are what drive many scientists to answer previously unsolved questions, collect new findings, and sometimes even open up completely new fields of research. These fields include the first human brain organoid and the CRISPR/Cas9 “gene shears”, both developed in Vienna. Each has enormous potential for modern medicine. But biotechnological innovations lead to any number of questions and pose new challenges for our society.

March 29, 2017

Unique genome architectures after fertilisation in single-cell embryos

Using a newly developed method researchers at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) have been able to shed light on the complexity of genome reorganization occurring during the first hours after fertilization in the single-cell mammalian embryo. Their findings have recently been published in the journal Nature. The team of researchers (from three continents) have discovered that the egg and sperm genomes that co-exist in the single-cell embryo or zygote have a unique structure compared to other interphase cells. Understanding this specialized chromatin “ground state” has the potential to provide insights into the yet mysterious process of epigenetic reprogramming to totipotency, the ability to give rise to all cell types.

March 10, 2017

Life scientists move into the mechanisms of self-organization in small brain-like structures

How close to reality are brain organoids, and which molecular mechanisms underlie the remarkable self-organizing capacities of tissues? Researchers already have succeeded in growing so-called “cerebral organoids” in a dish - clusters of cells that self-organize into small brain-like structures. Juergen Knoblich and colleagues have now further characterized these organoids and publish their results today in The EMBO Journal. They demonstrate that, like in the human brain, so-called forebrain organizing centers orchestrate developmental processes in the organoid, and that organoids recapitulate the timing of neuronal differentiation events found in human brains.

March 02, 2017

Kikuë Tachibana-Konwalski receives Walther Flemming Award

We are proud to announce that IMBA group leader and EMBO Young Investigator Kikuë Tachibana-Konwalski was awarded the Walther Flemming medal for her outstanding research achievements. She received this renowned award in cell biology at the annual spring Meeting of the German Society for Cell Biology March 2nd. Kikue is thrilled to receive the medal, especially since “Flemming has inspired generations of cell biologists and certainly my own research”, she says. The Walther Flemming Award is awarded to young scientists up to 38 years of age for outstanding scientific achievements from all areas of cell biological and consists of a medal and a prize money of EUR 2,000.

January 19, 2017

Scientists initiate first ethical guidelines for organs cultivated in vitro

In the latest edition of the professional journal “Science”, Jürgen Knoblich, a leading authority on stem cells and deputy director of the IMBA (Institute for Molecular Biotechnology of the Austrian Academy of Sciences), together with international experts, presents a first ethical guideline for research into human organ models. In the article, he also argues for critical and responsible engagement with the new technology.

January 03, 2017

IMBA – The year in review: 2016 brought top-level research funding and scientific milestones

In 2016, IMBA – Institute of Molecular Biotechnology at the Austrian Academy of Sciences received the prestigious “Proof of Concept” grant from the European Research Council (ERC) as well as two fellowships in the renowned EMBO Young Investigator Programme. A series of scientific achievements could pave the way for new treatment options in the future, including the possible prevention of breast cancer, new treatments for deadly fungal infections, and improvements in assisted reproduction.

The Vienna Biocenter in the third district of Vienna has established itself as the premier location for life sciences in Central Europe and is a world-leading international bio-medical research center.

 

visit the Website